The short-term effects of a body awareness program: better self-management of health problems for individuals with chronic a-specific psychosomatic symptoms

2004 ◽  
Vol 55 (2) ◽  
pp. 155-167 ◽  
Author(s):  
Jeanet J.A. Landsman-Dijkstra ◽  
Ruud van Wijck ◽  
Johan W. Groothoff ◽  
Piet Rispens
2019 ◽  
Author(s):  
Wim Veling ◽  
Bart Lestestuiver ◽  
Marieke Jongma ◽  
H J Rogier Hoenders ◽  
Catheleine van Driel

BACKGROUND Virtual reality (VR) relaxation is a promising mental health intervention that may be an effective tool for stress reduction but has hardly been tested in clinical trials with psychiatric patients. We developed an easy-to-use VR self-management relaxation tool (VRelax) with immersive 360° nature videos and interactive animated elements. OBJECTIVE To investigate the immediate effects of VR relaxation on negative and positive affective states and short-term effects on perceived stress and symptoms in patients with a psychiatric disorder, compared to standard relaxation exercises. METHODS A randomized crossover trial was conducted in 50 patients receiving ambulatory treatment for anxiety, psychotic, depressive, or bipolar disorder. Participants were randomly assigned to start with VRelax or standard relaxation and used both interventions for 10 days at home. They completed 8 visual analog scales of momentary negative and positive affective states before and after each session. Global perceived stress and psychiatric symptoms were measured before and after both intervention periods. Treatment effects were analyzed with multilevel mixed model regression analyses and 2-way analysis of variance. RESULTS Both VRelax and standard relaxation exercises led to a statistically significant immediate improvement of all negative and positive affective states. Compared to standard relaxation, VRelax resulted in a significantly greater reduction of total negative affective state (change 16.2% versus 21.2%; t<sub>1684</sub>=−2.02, 95% CI −18.70 to −0.28; <i>P</i>=.04). Specifically, VRelax had a stronger beneficial effect on momentary anxiety (t<sub>1684</sub>=−3.24, 95% CI −6.86 to −1.69), sadness (t<sub>1684</sub>=−2.32, 95% CI −6.51 to −0.55), and cheerfulness (t<sub>1684</sub>=2.35, 95% CI 0.51 to 5.75). There were no significant differences between short-term effects of the two treatments on global perceived stress and symptoms. CONCLUSIONS If the results of this trial are replicated and extended, VRelax may provide a much-needed, effective, easy-to-use self-management relaxation intervention to enhance psychiatric treatments. CLINICALTRIAL Netherlands Trial Register NTR7294; https://www.trialregister.nl/trial/7096


Author(s):  
Sophie Laforest ◽  
Kareen Nour ◽  
Monique A.M. Gignac ◽  
Lise Gauvin ◽  
Manon Parisien

RÉSUMÉUne étude a montré que le programmeMon arthrite, je m’en charge!pouvait réduire la perception des limitations fonctionnelles des participants du groupe expérimental, réduire leur sentiment d’impuissance et améliorer leur perception de gestion de la maladie. La présente étude examine le maintien de ces bénéfices et le rôle du renforcement social sur ce maintien, huit mois après l’intervention. Les mesures ont été prises à quatre temps: 1) mesure de base (n=125); 2) deux mois plus tard, avant randomisation (pré-intervention); 3) deux mois post randomisation (post-intervention) et 4) dix mois après la randomisation (post-intervention 2) (n=80). Un devis expérimental randomisé a été utilisé pour comparer trois groupes: le groupe témoin, le groupe expérimental sans renforcement social et le groupe expérimental avec renforcement social post-intervention (i.e., téléphones mensuels par un bénévole). Les analyses multiniveaux ont révélé que les participants du groupe expérimental avec renforcement social ont continué à rapporter moins de limitations fonctionnelles (p= 0.05) et une meilleure perception de gestion de la maladie (p=0.07) que les participants du groupe expérimental sans renforcement social. Cette étude fournit des preuves préliminaires sur la valeur ajoutée des renforcements post-intervention pour maintenir les effets d’un programme d’autogestion chez des aînés frêles, confinés à domicile.


2008 ◽  
Vol 27 (5) ◽  
pp. 539-567 ◽  
Author(s):  
Sophie Laforest ◽  
Kareen Nour ◽  
Monique Gignac ◽  
Lise Gauvin ◽  
Manon Parisien ◽  
...  

2021 ◽  
Author(s):  
Hans Hvide ◽  
Julian Johnsen

Abstract Existing research has found negative short-term consequences of the COVID-19 pandemic on mental health problems, but longer-term effects have been less documented. Using newly released register data on all general practitioner consultations in Norway through 2020 (about 14 million consultations in total), we find that during the spring and early summer 2020, the number of psychological cases initially increased relative to prior years, but then fell back towards the level of prior years during the summer 2020. In early September 2020, the number of cases accelerated, a pattern that held up through December 2020, so that the gap between 2020 and prior years became largest end-of-year. Our findings suggest that the accumulated effects of the COVID-19 pandemic on mental health far exceeds the short-term effects. The effects were particularly strong for females and for residents in urban areas.


10.2196/17233 ◽  
2021 ◽  
Vol 23 (1) ◽  
pp. e17233
Author(s):  
Wim Veling ◽  
Bart Lestestuiver ◽  
Marieke Jongma ◽  
H J Rogier Hoenders ◽  
Catheleine van Driel

Background Virtual reality (VR) relaxation is a promising mental health intervention that may be an effective tool for stress reduction but has hardly been tested in clinical trials with psychiatric patients. We developed an easy-to-use VR self-management relaxation tool (VRelax) with immersive 360° nature videos and interactive animated elements. Objective To investigate the immediate effects of VR relaxation on negative and positive affective states and short-term effects on perceived stress and symptoms in patients with a psychiatric disorder, compared to standard relaxation exercises. Methods A randomized crossover trial was conducted in 50 patients receiving ambulatory treatment for anxiety, psychotic, depressive, or bipolar disorder. Participants were randomly assigned to start with VRelax or standard relaxation and used both interventions for 10 days at home. They completed 8 visual analog scales of momentary negative and positive affective states before and after each session. Global perceived stress and psychiatric symptoms were measured before and after both intervention periods. Treatment effects were analyzed with multilevel mixed model regression analyses and 2-way analysis of variance. Results Both VRelax and standard relaxation exercises led to a statistically significant immediate improvement of all negative and positive affective states. Compared to standard relaxation, VRelax resulted in a significantly greater reduction of total negative affective state (change 16.2% versus 21.2%; t1684=−2.02, 95% CI −18.70 to −0.28; P=.04). Specifically, VRelax had a stronger beneficial effect on momentary anxiety (t1684=−3.24, 95% CI −6.86 to −1.69), sadness (t1684=−2.32, 95% CI −6.51 to −0.55), and cheerfulness (t1684=2.35, 95% CI 0.51 to 5.75). There were no significant differences between short-term effects of the two treatments on global perceived stress and symptoms. Conclusions If the results of this trial are replicated and extended, VRelax may provide a much-needed, effective, easy-to-use self-management relaxation intervention to enhance psychiatric treatments. Trial Registration Netherlands Trial Register NTR7294; https://www.trialregister.nl/trial/7096


Sign in / Sign up

Export Citation Format

Share Document